Pfizer Inc. has sold its global Hospira Infusion Systems (HIS) business to ICU Medical Inc., the medical equipment manufacturer, for a total amount of around $900 m. The product portfolio sold includes IV pumps, solutions and medical devices. This operation is part of Pfizer’s strategy to refocus on its pharmaceutical portfolio and to divest certain smaller non-core businesses.
 
ICU Medical was advised in France by Baker McKenzie, with Guillaume Nataf, Partner, Diane Kisler, Associate, in M&A; Marie-Laëtitia de La Ville-Baugé, Counsel, in Public law; Stéphane Taïeb, Partner, and Charles Baudoin, Senior Associate, in Tax; Julie Yeni, Partner, and Sara Koski, Associate, in Life Sciences; Gilles Jolivet, Partner, Jérémie Paubel, Partner, and Julian Kisslinger, Associate, Labour law; Corentin Dolivet and Céline Gronier, Associates, in Real Estate.